subcutaneous xenotransplanted tumors; tumor tissues
HeLa
cell line-derived xenograft
NF-kappaB (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); autophagy (promotes); angiogenesis (promotes); ubiquitination (inhibits); ceRNA regulation (promotes); other pathway/process (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; RNA-seq; FISH / smFISH; RIP (RNA Immunoprecipitation); RNA Pull-Down; Co-IP; Luciferase Reporter Assay; Transfection; MTT; Transwell Assay; Tube Formation Assay; IF (Immunofluorescence); In Vivo Animal Model; IHC (Immunohistochemistry); Western Blot; Bioinformatics Analysis
circDMD may provide a new potential biomarker for cervical cancer.
circDMD is a TNFalpha-induced circRNA derived from DMD that promotes cervical cancer tumorigenesis. It activates NF-kappaB signaling through P65/P50 interaction, a miR-4711-5p/KDM5A/SOCS1 ubiquitination-related mechanism, and R-loop formation at the VEGFR3 promoter, thereby enhancing proliferation, metastasis, autophagy, angiogenesis, and xenograft tumor growth.
0.8599
Inflammatory factor TNFalpha-induced circDMD mediates R-loop formation to promote tumorigenesis.
biological research